Literature DB >> 28268166

Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.

Yue Li1, Zhenzhen Wu1, Jia Yuan1, Li Sun1, Li Lin1, Na Huang1, Jianping Bin2, Yulin Liao2, Wangjun Liao3.   

Abstract

MALAT1 is an oncogenic long non-coding RNA that has been found to promote the proliferation of many malignant cell types and non-malignant human umbilical vein endothelial cells (HUVECs). However, the functions of MALAT1 in vasculogenic mimicry (VM) and angiogenesis and the potential mechanisms responsible have not yet been investigated in any malignancy. Here, in situ hybridization and CD31/periodic acid-Schiff double staining of 150 gastric cancer (GC) clinical specimens revealed that MALAT1 expression was tightly associated with densities of VM and endothelial vessels. MALAT1 knockdown markedly reduced GC cell migration, invasion, tumorigenicity, metastasis, and VM, while restricting HUVEC angiogenesis and increasing vascular permeability. Moreover, MALAT1 was found to regulate expression of VE-cadherin, β-catenin, MMPs 2 and 9, MT1-MMP, p-ERK, p-FAK, and p-paxillin, which have been established as classical markers of VM and angiogenesis and components of associated signaling pathways. Consistent with this, the p-ERK inhibitors U0126 and PD98059 both effectively blocked GC cell VM. In conclusion, MALAT1 can promote tumorigenicity and metastasis in GC by facilitating VM and angiogenesis via the VE-cadherin/β-catenin complex and ERK/MMP and FAK/paxillin signaling pathways.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Gastric cancer; VE-cadherin/β-catenin complex; Vasculogenic mimicry; lncRNA MALAT1

Mesh:

Substances:

Year:  2017        PMID: 28268166     DOI: 10.1016/j.canlet.2017.02.035

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  79 in total

1.  LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.

Authors:  Jing Zhao; Peizhun Du; Peng Cui; Yunyun Qin; Cheng'en Hu; Jing Wu; Zhongwen Zhou; Wenhong Zhang; Lunxiu Qin; Guangjian Huang
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

2.  An upstream open reading frame regulates vasculogenic mimicry of glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 pathway.

Authors:  Mo Wang; Chunqing Yang; Xiaobai Liu; Jian Zheng; Yixue Xue; Xuelei Ruan; Shuyuan Shen; Di Wang; Zhen Li; Heng Cai; Yunhui Liu
Journal:  J Cell Mol Med       Date:  2020-05-05       Impact factor: 5.310

3.  HOTAIR contributes to the growth of liver cancer via targeting miR-217.

Authors:  Li-Ping Wang; Jun-Ping Wang; Xin-Ping Wang
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

Review 4.  Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis.

Authors:  Jing Zhao; Li Li; Zhong-Ying Han; Zheng-Xin Wang; Lun-Xiu Qin
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

5.  LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.

Authors:  Yanbei Sun; Tingxiu Jiang; Yongqing Jia; Jingyun Zou; Xiaoxiao Wang; Weiying Gu
Journal:  Cell Cycle       Date:  2019-08-09       Impact factor: 4.534

6.  lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression.

Authors:  Mingyan Huang; Huamin Wang; Xiang Hu; Xuetao Cao
Journal:  Oncoimmunology       Date:  2018-10-16       Impact factor: 8.110

7.  Long non-coding RNA MALAT1 enhances angiogenesis during bone regeneration by regulating the miR-494/SP1 axis.

Authors:  Ao Ding; Cheng-Hua Li; Chan-Yuan Yu; Hang-Tian Zhou; Zhi-Hong Zhang
Journal:  Lab Invest       Date:  2021-08-14       Impact factor: 5.662

Review 8.  The regulatory roles and potential prognosis implications of long non-coding RNAs in gastric cancer.

Authors:  Yue Wang; Fan Yang; Qing Yang
Journal:  Histol Histopathol       Date:  2019-12-03       Impact factor: 2.303

9.  The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.

Authors:  Zhangding Wang; Qiang Wang; Guifang Xu; Na Meng; Xinli Huang; Zerun Jiang; Chen Chen; Yan Zhang; Junjie Chen; Aiping Li; Nan Li; Xiaoping Zou; Jianwei Zhou; Qingqing Ding; Shouyu Wang
Journal:  RNA Biol       Date:  2020-01-07       Impact factor: 4.652

10.  Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation.

Authors:  Yuhao Luo; Siting Zheng; Qianying Wu; Jianhua Wu; Rui Zhou; Chunling Wang; Zhenzhen Wu; Xiaoxiang Rong; Na Huang; Li Sun; Jianping Bin; Yulin Liao; Min Shi; Wangjun Liao
Journal:  Autophagy       Date:  2021-03-25       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.